Mattias Höglund
111 – 120 of 163
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Wilms tumors develop through two distinct karyotypic pathways.
(
- Contribution to journal › Article
-
Mark
High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation.
(
- Contribution to journal › Article
-
Mark
Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas.
(
- Contribution to journal › Article
-
Mark
Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines.
(
- Contribution to journal › Article
- 2003
-
Mark
Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate.
(
- Contribution to journal › Article
-
Mark
Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors
(
- Contribution to journal › Article
-
Mark
A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences.
(
- Contribution to journal › Article
-
Mark
Power law distribution of chromosome aberrations in cancer.
(
- Contribution to journal › Article
-
Mark
Pancreatic carcinoma cell lines with SMAD4 inactivation show distinct expression responses to TGFB1.
(
- Contribution to journal › Article
-
Mark
Vitamin d receptor is expressed in pancreatic cancer cells and a vitamin d(3) analogue decreases cell number.
(
- Contribution to journal › Article